Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Radiopharmaceuticals technetium

Technetium chemistry and technetium radiopharmaceuticals. E. Deutsch, K. Libson, S. Jurisson and L. F. Lindoy, Prog. Inorg. Chem., 1983, 30, 75-139 (279). [Pg.30]

Deutsch, E. Libson, K. Jurisson, S. Lindoy, L. F., Ed., Technetium Chemistry and Technetium Radiopharmaceuticals 1983, iOWiley New York. [Pg.258]

By far, the largest number of structurally characterized rhenium complexes contain the metal in the oxidation state +5 . This can be attributed to the high stability of the rhenium(V) oxo, nitrido, and imido cores with a great variety of ligand systems, but is doubtlessly also related to the fact that rhenium complexes are frequently used as nonradioactive model compounds for the development of technetium radiopharmaceuticals. The dominance of 0 , and NR ligands can be... [Pg.286]

Special attention has been paid to Re, since this isotope can readily be obtained from isotope generators which are based on the decay of (physical ti/2 = 69.4 d) in a matrix from which the daughter nuclide Re can readily be separated. This permits continuous availability of the radioisotope at the clinic and allows the preparation of Re-radiopharmaceuticals in a kit procedure as has been established for technetium radiopharmaceuticals. W/ Re generators... [Pg.380]

Finally, while the new synthetic methods for technetium compounds in the oxidation states I, II and V will undoubtedly play an important role in the development of improved radioscintigraphic agents, there remains a need to understand the chemical mechanisms involved in these syntheses, particularly with regard to ligand substitution reactions and atom transfer redox processes. Mechanistic studies to complement the increasing body of structural knowledge is essential to the further development of technetium radiopharmaceuticals. [Pg.74]

The mid- to late 1980s saw an increasing emphasis on designing technetium radiopharmaceuticals that have specific interaction with cellular proteins and/or receptors. [Pg.5479]

Deutsch E, Libson K, Jurisson S, Lindoy LF (1983) Technetium chemistry and technetium radiopharmaceuticals In Lippard SJ (ed) Progress in inorganic chemistry. Wiley, New York, pp 75-139 Deutsch E, Vanderheyden J-L, Gerundini P, Libson K et al (1987) Development of non reducible technetium-99m(III) cations as myocardial perfusion imaging agents initial experience in humans. J Nucl Med 28 1870-1880... [Pg.23]

Simms MS, Perkins AC, Price MR et al (2001) Technetiiun-C595 radioimmimoscintigraphy a potential staging tool for bladder cancer. BJU Int 88 686-691 Spies H, Pietzsch HJ, Johannsen B (1999) The n+I mixed-ligand approach in the design of specific technetium radiopharmaceuticals potentials and problems. In Nicolini M, Mazzi U (eds) Tc, Re and other metals in chemistry and nuclear medicine, vol. 5. SG Editoriali, Padova, Italy, pp 101-108... [Pg.57]

Noronha OPD (1978) Time-dependent characteristics on Sn-complexes for preparing c-la-belled radiopharmaceuticals and their bioavailabihties - a review. Nuklearmedizin 17 110-125 Novotnik DP (1990) Physico-chemical concepts in the preparation of technetium radiopharmaceuticals. In Sampson CB (ed) Textbook of radiopharmacy theory and practice. Gordon and Breach, Philadelphia, pp 29-49... [Pg.66]

Syhre R, Spies H, Johannsen B (1976) Die Organverteilung von " TcJSnJ-Hydroxidkolloid in der Ratte in Abhangigkeit vom Praparations-pH [in German]. Radiobiol Radiother 17 747-750 Thomas RW, Estes GW, Elder RC (1979) Technetium radiopharmaceutical development. I. Synthesis, characterization and structure of dichloro[hydrotris(l-pyrazolyl)borate]oxo-technetium(V). J Amer Chem Soc 101 4581... [Pg.66]

Mallol J, Bonino C (1997) Comparison of radiochemical purity control methods for technetium radiopharmaceuticals used in hospital radiopharmacy. Nucl Med Com-mun 18 419-422... [Pg.344]

Jesus Mallol, Ph.D, September 1995 Comparison of radiochemical purity control methods for technetium radiopharmaceuticals used in hospital radiopharmacy. Sorin Bio-medica S.p.A., Radiopharmaceutical Development, Saluggia, Italy Martina Netter, M.Sc., 3-21 June 1996 Study of methods to enhance the stability of the " Tc-HM-PAO complex. Addenbrooke s Hospital, Cambridge, UK... [Pg.345]

Deutsch, Edward, Libson, Karen, Jurisson, Silvia and Lindoy, Leonard E, Technetium Chemistry and Technetium Radiopharmaceuticals. .., Diamond, R. M. and Tuck, D. G., Extraction of Inorganic Compounds... [Pg.527]

See other pages where Radiopharmaceuticals technetium is mentioned: [Pg.3]    [Pg.629]    [Pg.380]    [Pg.382]    [Pg.435]    [Pg.882]    [Pg.996]    [Pg.522]    [Pg.101]    [Pg.73]    [Pg.74]    [Pg.137]    [Pg.726]    [Pg.193]    [Pg.572]    [Pg.5478]    [Pg.882]    [Pg.996]    [Pg.478]    [Pg.435]    [Pg.471]    [Pg.746]    [Pg.514]    [Pg.23]    [Pg.46]    [Pg.341]    [Pg.669]    [Pg.453]    [Pg.304]    [Pg.5477]    [Pg.7027]    [Pg.7141]    [Pg.628]    [Pg.160]    [Pg.92]   
See also in sourсe #XX -- [ Pg.882 ]

See also in sourсe #XX -- [ Pg.882 ]

See also in sourсe #XX -- [ Pg.514 , Pg.515 ]

See also in sourсe #XX -- [ Pg.6 , Pg.882 , Pg.972 ]



SEARCH



Radiopharmaceutical

Radiopharmaceutical agents technetium essential

Technetium

Technetium Tagged Radiopharmaceuticals

Technetium complexes radiopharmaceuticals

Technetium essential radiopharmaceuticals

© 2024 chempedia.info